Welcome to the Gateway Analytical Monthly Technical Briefing!
Every month, we’ll bring you the latest on evolving regulatory expectations, upcoming industry events, and key insights to keep your projects & drug products on track. We are your go-to resource for analytical testing tools, and specialized consulting, designed to make sure you stay ahead of the curve.
| Empowering partners and customers via pre-clinical guidance, and trusted analytical testing on your regulatory journey. |
| Sharing insights and updates on the constantly evolving regulatory expectations across the globe for 2026. |
| Get inspired by subject matter experts and leading scientists through conference attendance, webinars, and keynote sessions. |
Beyond Compliance: The Defensibility Gap in Subvisible Particle Testing
In the evolving regulatory climate of 2026, regulators are looking beyond simple pass/fail metrics toward the scientific justification and data supporting drug product safety. For complex drug products, such as high-concentration proteins or viral vectors, standard testing settings may not provide a complete picture of your particulate population.
Getting Ahead of the Curve: Closing the Gap Before the Audit
Many organizations still rely on outdated method suitability data that was generated during early-phase development, data that often lacks the rigor required for a commercial filing in 2026.
“Regulatory readiness requires more than just a passing result; it requires scientifically defensible data. Proving that your chosen methods are capable of detecting risk within your unique formulation, remains an important obstacle on your journey to market. We’re here to help.”
— Gateway Analytical Technical Leadership
Method Verification Gap Check & Strategy Review
Our Method Verification Gap Check & Strategy Review is a 30-minute high-level review designed to identify vulnerabilities in your subvisible & visible particle data package. We evaluate your current protocols and operations against evolving regulatory expectations to ensure that when the PAI (Pre-Approval Inspection) occurs, your data is already defensible.
Choose an expert from Gateway Analytical to conduct your drug product Strategy Review. See how our team can help operationalize and optimize your drug product!
Advanced Therapies Week 2026 – Join Our Director of Sales & Marketing!
Shaping the Future of Advanced Therapies
Join our Director of Sales and Marketing at the San Diego Convention Center, February 9–12, 2026, to get connected with our team and learn more about the cell and gene therapy ecosystem. We look forward to discussing how Gateway Analytical can support your journey from R&D to clinical success through specialized particulate analysis and method verification tailored to the needs of your most complex drug products!
This event is a critical hub for the cell and gene therapy community, focusing on the commercialization and manufacturing scale-up of next-generation medicines. We look forward to discussing how Gateway Analytical can support your journey from R&D to clinical success through specialized particulate analysis and method verification.
Looking Forward to 2026 and Beyond with Gateway Analytical..
From shifting regulatory landscapes to the industry’s biggest events, we provide the analytical tools and specialized consulting you need to keep your projects moving forward. Let’s stay ahead of the curve, together.
Reach out today for a priority consultation: 📞 (724) 443-1900 | ✉️ in**@***************al.com
